News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
JOYCE R TODD
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/13/2014 |
4
| JOYCE R TODD (CFO-Global) has filed a Form 4 on Actavis plc|
Txns:
| Granted 2,537 shares
@ $197.05, valued at
$499.9k
|
|
| 12/06/2013 |
4
| JOYCE R TODD (CFO-Global) has filed a Form 4 on Actavis plc|
Txns:
| Sold 7,500 shares
@ $165.51, valued at
$1.2M
Sold 7,100 shares
@ $166.16, valued at
$1.2M
|
|
| 11/07/2013 |
4
| JOYCE R TODD (CFO-Global) has filed a Form 4 on Actavis plc|
Txns:
| Sold 15,000 shares
@ $157.01, valued at
$2.4M
Sold 7,500 shares
@ $158.42, valued at
$1.2M
|
|
| 10/10/2013 |
4
| JOYCE R TODD (CFO-Global) has filed a Form 4 on Actavis plc|
Txns:
| Gifted 54,379 shares
@ $0
Gifted 54,379 shares
@ $0
Gifted 19,438 shares
@ $0
Gifted 19,438 shares
@ $0 |
|
| 10/03/2013 |
4
| JOYCE R TODD (CFO-Global) has filed a Form 4 on Actavis plc|
Txns:
| Granted 73,812 shares
@ $0
Granted 3,283 shares
@ $0 |
|
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/18/2013 |
4
| JOYCE R TODD (CFO-Global & PAO) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 931 shares
@ $91.59, valued at
$85.3k
|
|
| 03/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2013 |
4
| JOYCE R TODD (CFO-Global & PAO) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 1,919 shares
@ $86.46, valued at
$165.9k
|
|
| 03/05/2013 |
4
| JOYCE R TODD (CFO-Global & PAO) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 3,834 shares
@ $85.54, valued at
$328k
|
|
| 08/01/2012 |
4
| JOYCE R TODD (CFO-Global & PAO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 2,612 shares
@ $78.6, valued at
$205.3k
Sold 4,388 shares
@ $78.6, valued at
$344.9k
Sold 2,250 shares
@ $78.6, valued at
$176.9k
Sold 574 shares
@ $78.6, valued at
$45.1k
Exercised 2,612 options to buy
@ $38.92, valued at
$101.7k
Exercised 4,388 options to buy
@ $38.92, valued at
$170.8k
Exercised 2,250 options to buy
@ $35.11, valued at
$79k
Exercised 574 options to buy
@ $25.64, valued at
$14.7k
Exercised 3,426 options to buy
@ $25.64, valued at
$87.8k
|
|
| 05/29/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2012 |
4
| JOYCE R TODD (Exec Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,067 shares
@ $59.21, valued at
$63.2k
|
|
| 03/12/2012 |
4
| JOYCE R TODD (Exec Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 8,356 shares
@ $0
Granted 7,698 shares
@ $0 |
|
| 02/28/2012 |
4
| JOYCE R TODD (Exec Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,625 shares
@ $58.17, valued at
$94.5k
|
|
| 11/01/2011 |
4
| JOYCE R TODD (Exec Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,175 shares
@ $69.35, valued at
$81.5k
|
|
| 08/26/2011 |
4
| JOYCE R TODD (Exec Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 6,616 shares
@ $65.46, valued at
$433.1k
Sold 2,924 shares
@ $65.46, valued at
$191.4k
Exercised 3 options to buy
@ $27.88, valued at
$83.6
Exercised 2,141 options to buy
@ $26.4, valued at
$56.5k
Exercised 2,854 options to buy
@ $26.4, valued at
$75.3k
Exercised 4,142 options to buy
@ $26.14, valued at
$108.3k
Exercised 7,858 options to buy
@ $26.14, valued at
$205.4k
Exercised 750 options to buy
@ $35.11, valued at
$26.3k
|
|
| 07/28/2011 |
4
| JOYCE R TODD (Exec Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 7,202 shares
@ $68.41, valued at
$492.7k
Exercised 5,855 options to buy
@ $64.18, valued at
$375.8k
Exercised 147 options to buy
@ $64.18, valued at
$9.4k
Exercised 1,498 options to buy
@ $64.18, valued at
$96.1k
|
|
| 05/05/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2011 |
4
| JOYCE R TODD (Exec Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 544 shares
@ $56.89, valued at
$30.9k
Granted 3,594 shares
@ $0 |
|
| 03/08/2011 |
4
| JOYCE R TODD (Sr Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,374 shares
@ $56.79, valued at
$78k
|
|
| 03/07/2011 |
4
| JOYCE R TODD (Sr Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 10,978 shares
@ $57.09, valued at
$626.7k
Exercised 7,497 options to buy
@ $27.88, valued at
$209k
Exercised 6,500 options to buy
@ $48.9, valued at
$317.9k
|
|
| 12/15/2010 |
4
| JOYCE R TODD (Sr Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $49.7, valued at
$248.5k
Sold 3,715 shares
@ $49.5, valued at
$183.9k
Sold 1,285 shares
@ $49.5, valued at
$63.6k
Exercised 8,715 options to buy
@ $46.31, valued at
$403.6k
Exercised 1,285 options to buy
@ $46.31, valued at
$59.5k
|
|
| 12/14/2010 |
4
| JOYCE R TODD (Sr Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 792 shares
@ $49.01, valued at
$38.8k
Sold 1,708 shares
@ $49, valued at
$83.7k
Exercised 1,367 options to buy
@ $45.875, valued at
$62.7k
Exercised 1,133 options to buy
@ $45.875, valued at
$52k
|
|
| 09/02/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2010 |
4
| JOYCE R TODD (Sr Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,192 shares
@ $41.37, valued at
$49.3k
|
|
| 10/30/2009 |
4
| JOYCE R TODD (Sr Vice Pres. & CFO) has filed a Form 4 on WATSON PHARMACEUTICALS INC |
| 08/13/2009 |
4
| JOYCE R TODD (VP, Corp. Controller & Treas.) has filed a Form 4 on WATSON PHARMACEUTICALS INC |
|
|